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Abstract 
When artificial materials come into contact with blood, various biological responses are 
induced. For successful development of biomaterials used in biomedical devices that 
will be exposed to blood, understanding and control of these interactions are essential. 
Surface plasmon resonance (SPR) spectroscopy is one of the surface-sensitive optical 
methods to monitor biological interactions. SPR enables real-time and in situ analysis of 
interfacial events associated with biomaterials research. In this review, we describe a 
SPR biosensor and its application to monitor complement activation onto biomaterials 
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1. Introduction 
When artificial materials come into contact with blood, various biological responses, 
such as adsorption of proteins, activation of the complement and coagulation systems, 
platelet activation, inflammatory reactions and cell adhesion are induced. Control of 
these interactions is essential for the development of biomaterials used in the 
preparation of biomedical devices. Thus, extensive studies have been performed to 
understand the interactions of blood with artificial materials. 
The complement system is a cascade of enzyme reactions consisting of approximately 
thirty fluid-phase and cell-membrane bound proteins. It plays an important role in the 
body’s defense systems against pathogenic xenobiotics [1,2] and is also activated by 
artificial polymeric materials. For example, hemodialysis membranes made of cellulose 
or its derivatives strongly activate the complement system and this process has been 
extensively studied [3,4]. Information on the complement activation by artificial 
materials also has accumulated from various clinical settings, such as open heart surgery, 
blood transfusion medicine, and extracorporeal immunotherapies [6-8]. Understanding 
of complement activation on the surfaces of artificial materials is important to the 
rational design of biocompatible surfaces of synthetic materials.  
Complement fragments, such as C3a, iC3b, C5a, and SC5b-9, are released when 
artificial surfaces are exposed to serum. The interaction of complement proteins with 
material surfaces has been studied using enzyme-linked immunosorbent assay (ELISA) 
for these complement fragments study [8-14]. Recently, various analytical techniques 
have been examined to study biomaterials, but few of these are able to monitor dynamic 
interactions under physiological conditions. Surface plasmon resonance (SPR) is a 
surface-sensitive optical technique that allows us to follow refractive index changes 
near a metal surface and thus has been widely used for real-time investigations of 
various dynamic biological processes, such as protein-protein, DNA-DNA and protein-
DNA interactions, without the need to label the sample [15-19]. For complement 
research, SPR has been applied to monitor individual biomolecular interactions between 
complement components and thus has been used to determine their rate constants and 
affinity constants. It has been also applied to examine formation of complement 
complexes such as C3 and C5 convertases. Application of SPR for these purposes has 
been reviewed by Ricklin and Lambris [20]. SPR also allows us to study interfacial 
events relating to biomaterial research since various model surfaces can be prepared on 
a SPR sensor chip. 
In this review, we describe application of the SPR method to study interactions of the 
complement system with biomaterials. 
 
2. Surface plasmon resonance (SPR) 
2.1. Principle 
A surface plasmon is a longitudinal charge density wave that is propagated in a parallel 
manner along the interface of two media, where one surface is a metal and the other is a 
dielectric layer [21]. Metal is an essential component since the metal must exhibit free 
electron behavior as described by the free electron model [22]. Thus, metals like gold, 
silver, copper and aluminum are good candidates for optical excitation of surface 
plasmons, and so far most of the experimental work has been performed on gold and 
silver. In SPR sensors, the surface plasmon is excited by a light wave. Two different 
settings of optical units for the excitation of surface plasmons have been reported by 
Otto [23] and Kretchmann [24]. The Kretchmann configuration based on the total 
internal reflection (ATR) has been widely used for development of SPR instruments. 
In the Kretchmann configuration (Fig. 1 (a)), a beam of p-polarized light (light that is 
polarized in a plane parallel to the plane of the incident light) is used to illuminate the 
back side of a gold thin film (typically ~ 50 nm) on glass through a prism, and the front 
side of the film faces air or a solution of interest. When the incident angle of p-polarized 
light exceeds the critical angle, the incident light is totally reflected. A small part of the 
light penetrates outside the glass, and this part of the light, the so-called evanescent 
wave, allows us to monitor events occurring on the metal/ambient interface. The wave 
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where ω is the frequency of incident light, c is the speed of the light, εg is the dielectric 
constant of glass (εg
1/2 corresponds to refractive index of glass), and θ is the incident 
angle. The dispersion relation for a surface plasmon propagating along the interface 
between a metal with a complex dielectric function ε(ω) = ε’(ω) + iε”(ω) and a 
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where ksp is the wave vector for the propagating surface plasmon along the interface. 
The evanescent wave of the incident light is able to couple with a surface plasmon at a 
specific incident angle, θSPR, where ksp = kev, resulting in the energy loss of the incident 
light to the metal film and is observed as a minimum in the reflected light intensity (Fig. 
1 (b)). Therefore, the SPR angle (θSPR) depends on the refractive index of the medium in 
the vicinity of the metal film. Changes in the refractive index above the metal surface 
caused by various biological processes, such as adsorption of proteins, result in an 
increase of θSPR. 
Although various SPR experimental settings have been proposed including use of a 
wavelength-variable light source and a diffraction grating to couple incoming light with 
surface plasmon [18,19,21], the electromagnetic field of a surface plasmon is confined 
at the metal – dielectric boundary and decays exponentially with ~ 200 nm of a typical 
penetration depth in common. SPR spectroscopy is a sensitive methodology to monitor 
changes in the refractive index near the metal surface and has the advantage that 
analytes do not need to be labeled. 
 
2.2. Real-time monitoring 
The optical construction of an SPR instrument is simple, as shown schematically in Fig. 
1 (c). The SPR sensor is a glass plate coated with a gold (~ 50 nm) with an underlayer 
of chromium (~ 1 nm) as an adhesive layer. The plate is optically coupled to a glass 
prism using an index-matching fluid. A p-polarized laser beam is directed to the back 
side of a sample plate through a glass prism and reflected light intensity is monitored. 
By changing the incident angle of the laser beam, we can determine the SPR angle 
(θSPR) as the minimum in reflectance (Fig. 1 (b)). If substances are deposited onto the 
sensor surface, a shift in θSPR occurs (∆θSPR) in a manner dependent on the amount of 
the deposited substances. 
For real-time monitoring, the reflected light intensity is detected with respect to time 
(Fig. 2). Initially, a buffer solution is infused into a flow cell which is set up on the 
sensor surface to obtain a baseline (Fig. 2, process I). When a protein solution is 
subsequently circulated, a large increase in reflectance is observed due to the change in 
the refractive index of the solution (bulk effect) and the adsorption of proteins (Fig. 2, 
II). After circulation of the protein solution for a predetermined period (Fig. 2, III), a 
buffer solution is infused to wash the protein solution out and to remove loosely bound 
proteins (Fig. 2, IV). An increase in reflectance (∆R) can be converted to the SPR angle 
shift (∆θSPR) and the amount of adsorbed proteins is calculated from ∆θSPR. The 
thickness of the protein layer, the amount of protein adsorbed, was calculated from the 
shift in the SPR angle (∆θSPR) using Fresnel fits for the system 
glass/Cr/Au/SAM/protein/water [25,26].  
 
2.3. Comparison to other analytical techniques 
Various analytical methods have been developed to study interactions between 
biomolecules [27,28]. Some of them have been applied to monitor complement 
activation on biomaterials (Table 1). 
Ellipsometry has been used to probe proteins at interfaces, and has been applied to 
blood coagulation [29-32] and complement activation [33-40]. Ellipsometry allows for 
determination of the amount of protein adsorbed on reflecting materials such as silicon 
wafers and gold-coated silicon. The amount of adsorbed proteins can be determined in 
air and also in solution. Therefore, ellipsometry and SPR give similar information on 
proteins adsorbed onto the material surface, although the setting of optical units of SPR 
is simple compared to that of ellipsometry. 
The quartz crystal microbalance (QCM) has also been used to study complement 
activation on material surface [41-43]. An increase in mass bound to the quartz surface 
causes the crystal’s oscillation frequency to decrease, allowing for label-free and real-
time monitoring. A recently developed QCM with dissipation monitoring (QCM-D) 
allows simultaneous and simple measurements of changes in adsorbed mass as well as 
in the viscoelastic property of the deposited protein layers on the sensor surface [44]. 
Simultaneous analysis by QCM-D and SPR has been reported to provide several types 
of information about the adsorbed substances, such as the adsorbed mass and the 
coupled water mass [45]. 
Complement activation by biomaterials has been studied using enzyme-linked 
immunosorbent assay (ELISA) [8-14]. In these experiments, complement fragments, 
such as C3a, iC3b, C5a, and SC5b-9, released into serum were determined after 
exposure of sample surfaces to human serum. In contrast, SPR detects dynamic 
processes of protein deposition on the surface. Subsequent binding of antibodies allows 
for identification of the deposited proteins without the need for additional labeling. 
Therefore, ELISA and SPR measurements provide complementary approaches to 
examine complement activation on material surface. 
 
3. Model surfaces 
A metal-coated glass plate is used as a sensor chip in SPR measurement. A thin model 
layer should be formed on the metal surface. Serum is then exposed to the model 
surface to examine complement activation on organic materials. Many methodologies 
have been reported to prepare a model organic layer on a metal surface (Fig. 3). 
 
3.1. Self-assembled monolayers of alkanethiols 
Self-assembled monolayers (SAMs) of alkanethiols, HS(CH2)nX in which X denotes 
various functional groups, are frequently used to prepare model surfaces [46-49]. 
Alkanethiols or alkanedisulfides chemisorb from a solution onto a metal surface such as 
gold, silver, and platinum. A gold thin layer on a glass plate is commonly used to form 
SAMs because it is easy to prepare and is stable in the ambient environment. The gold – 
sulfur bond is relatively stable with ∆Hº ≈ 28 kcal/mol [50,51]. In addition, van der 
Waals interaction between each alkyl chain leads to self-assembly of the alkanethiol.   
Alkanethiols carrying long alkyl chain (n > 11) form closely packed SAMs with 
approximately 21.4 Å2 of occupied area per molecule [52,53]. Due to anchoring of the 
thiol to gold and the close packing of the alkyl chain, another terminal group, X, is 
effectively displayed at the surface of the SAM. Alkanethiols with various functional 
groups, X, are commercially available. It is easy to prepare SAMs with different 
functional groups.  
In addition, surface properties of SAMs can be finely controlled by coadsorption of 
alkanethiols from their mixed solutions. The composition of alkanethiols in SAMs 
reflects the mole fraction of alkanethiols in solution, but is not the same as their 
composition in the solution. The composition of SAMs can be determined by 
spectroscopic methods such as Fourier transformed infrared – reflection adsorption 
spectroscopy (FTIR-RAS) and X-ray photoelectron spectroscopy (XPS). Figure 4 
summarizes mixed SAMs which are prepared from a mixture of hydroxyl-terminated 
alkanethiol (11-mercapto-1-undecanol) and methyl-terminated alkanethiols with 
different alkyl chain length  [54]. The surface composition of the alkanethiol in the 
mixed SAM was determined from the FTIR-RAS spectra using an absorption band 
assigned to the asymmetric stretching mode of the methyl groups. The surface fraction 
of the alkanethiols in the mixed SAM does not linearly reflect the mole fraction in the 
original solution (Fig. 4 (a)). Rather, it is highly dependent on the chain length of 
alkanethiols and the terminal functional groups [55, 56]. The water contact angle 
measurement indicates that mixed SAMs become more hydrophilic as the surface 
fraction of the hydroxyl-terminated alkanethiol increases (Fig. 4 (b)). Thus, the 
preparation of mixed SAMs from a mixture of different alkanethiols allows us to 
systematically change surface properties, and provides different kinds of model surfaces 
for studies of complement activation on artificial materials.  
 
3.2. Polymer thin layers 
Polymers have also been used to prepare model surfaces on SPR sensors. Water-soluble 
polymers, such as dextran [57] and poly(ethylene glycol) (PEG) [58], carrying thiol 
groups on side chains or at a chain end directly chemisorb onto the gold surfaces 
through gold – sulfur bond. Surface modification of the sensor surface with water-
soluble polymers has also been performed by covalently immobilization [59-61] or 
physical adsorption [62] on SAMs. For water-insoluble polymers such as polystyrene, 
thin films with various thicknesses can be easily prepared by the spin-coating onto 
sensor surfaces. 
It should be noted that SPR is used to monitor local changes in refractive index in the 
vicinity on the sensor surfaces. The decay length of the surface plasmon field is 
typically 200 nm from the metal surface [63]. If polymer layers on the sensor surface 
are thicker than the decay length, adsorption of proteins onto the polymer layer can 
hardly be determined by SPR. Therefore, the thickness of the polymer layers should be 
controlled to effectively monitor the interfacial events on the polymer layers. The 
thickness of the dry polymer layer is determined using SPR by fitting a parameter of 
Fresnel’s law for a multi-layer system to measured data with, for example, 
glass/Cr/Au/polymer/air [25,26]. Using the refractive indices of each layer, the 
thickness of the polymer layer can be obtained. For a substrate carrying a water-soluble 
polymer, swelling of the polymer layer must be taken into consideration. We 
successfully estimated the thickness of swelled polymer layers including poly(N-
isopropylacrylamide) (PNIPAAm) [64] and PVA [61] using SPR.  
 
3.3. Lipid bilayer membrane 
Activation of the complement system by the cell membranes of pathogenic xenobiotics 
is critical in the body’s defense. Since liposomes are used in pharmaceutical 
applications, it is also important to understand complement activation by liposomal 
membranes. Lipid membranes have been fabricated on solid substrates and these have 
been applied to the study of protein–lipid membrane interactions. Various methods have 
been reported to prepare lipid membranes onto an SPR sensor chip, including solid-
supported lipid bilayers, polymer-cushioned lipid bilayers, hybrid bilayers, and tethered 
lipid bilayers [65]. In each of these examples, lipid molecules in the membrane maintain 
its lateral mobility. In addition, incorporation of membrane proteins into the lipid 
membranes has been developed [66].  
 
4. Complement activation on model surfaces 
4.1. Monitoring of complement activation by SPR 
A typical SPR sensorgram obtained during exposure of human serum to an SPR sensor 
carrying a SAM composed of hydroxyl-terminated alkanethiols is shown in Figure 5 
[67]. The sensor surface was sequentially exposed to veronal buffer (VB), human serum, 
VB, and finally, a solution of anti-C3b antibody. The sudden increase of the SPR angle 
observed by exposure to human serum is due to the increase in the refractive index near 
the sensor surface (bulk effect) and non-specific adsorption of serum proteins. The SPR 
angle then gradually increased (see Fig. 5, inset in more detail) and leveled off, 
reflecting additional deposition of serum proteins on the surface. It is considered to be 
due to the complement activation on the surface. When C3b is deposited on the material 
surface, it forms C3 convertase C3bBb, which cleaves C3 in the vicinity of the surface 
into C3a and C3b. The rate of C3b deposition onto the surface is accelerated by an 
autocatalytic positive feedback mechanism after C3 convertase has been generated once. 
When the serum was removed by infusing VB into the flow cell, a slight decrease in the 
SPR angle occurred reflecting the change in the refractive index of the solution and the 
removal of loosely adsorbed proteins. The SPR angle shift (∆SPR in Figure 5) after 
rinsing with VB is attributed to serum protein adsorption and the amount of proteins on 
the surface can be calculated from the ∆SPR (see section 2.2). When the complement 
system is activated on the sensor surface, C3 fragments such as C3b and C3c are 
expected to be immobilized on the protein layer formed on the sensor surface. When a 
solution of antibody against C3 fragments was applied, the SPR angle should increase 
further. Figure 5 illustrates that the SPR angle actually increased during application of 
anti-C3b antiserum, indicating that large amount of C3b or C3bBb was deposited on the 
surface. Thus, SPR allows us to monitor the complement activation on the sensor 
surface. 
The above claim was supported by ELISA of the fragments of complement proteins 
produced during the complement activation. Human serum was incubated with surfaces 
and then concentrations of complement fragments or complex (C3a, Bb, C5a, or SC5b-
9) in it were determined by ELISA. Surfaces on which a large amount of anti-C3b 
antibody was deposited also produced fragments of complement proteins, such as Bb, 
C3a, C5a, and SC5b-9 in serum [60,61,67-70]. Combination of SPR and ELISA 
provides complementary information of complement activation behavior on material 
surfaces, while SPR is superior in rapid and real-time monitoring of complement 
activation compared to ELISA. 
The complement system has three activation pathways, the classical, alternative and 
lectin pathways. Activation of a specific pathway is highly dependent on the materials. 
The addition of specific reagents to serum can determine which pathway is activated. 
Ethylenediaminetetraacetic acid (EDTA) inhibits all three pathways. Ethylene glycol-
bis[β-aminoethyl ether]-N,N,N’,N’-tetraacetic acid (EGTA) and MgCl2 block only the 
classical pathway. The alternative pathway can be blocked by compstatin or its cyclic 
analog [71-73]. Use of serum depleted of complement protein or addition of antibodies 
against complement-relating proteins, auch as IgG, C1q, C4, also gives us additional 
information about the complement activation cascade including initiation, formation of 
C3 and C5 convertase.  
Monitoring of complement cascade on the surface by binding of specific antibodies 
should be carefully interpreted. Complement activation results in deposition of a large 
amount of complement proteins on the surface. Underlying proteins such as IgG, C1q, 
C4 are only transiently detected by specific antibodies due to steric hindrance by serum 
proteins deposited at late stage. This has been encountered regardless of apparatus 
employed, SPR or ellipsometry, when surface-bound antigens are detected using 
specific antibodies [34,36,37,42,74]. Therefore, comprehensive approaches including 
choice of serum incubation time, inhibitors, and detection of complement fragments by 
ELISA are required to conclude which complement cascade is activated on the surface. 
 
4.2. Complement activation on model surfaces 
Several mechanisms have been proposed to explain complement activation by artificial 
materials (Fig. 6).  Its activation is triggered by (a) nonspecifically adsorbed 
immunoglobulins; (b) conformational change of adsorbed C3 into a C3b-like structure; 
(c) covalent binding of C3b to adsorbed serum proteins; and (d) covalent binding of 
C3b to artificial materials.  
 
4.2.1. Complement activation by adsorbed proteins 
The classical pathway is initiated by antigen-antibody complexes formed onto 
pathogens. Few specific antibodies against artificial materials, such as antibodies 
against PEG [75], can activate the complement through the classical pathway. 
Nonspecific adsorption of immunoglobulins is thought to induce the complement 
activation through the classical pathway (Fig. 6 (a)). Preadsorption of IgG, IgA, or IgM 
to surfaces has been shown to induce strong complement activation [36,37,39,40,74]. 
Although preadsorbed immunoglobulins initiate the complement activation through the 
classical pathway, they can also be substrates for covalent binding of C3b which is 
generated in the liquid phase or during complement activation [42]. The 
immunoglobulin-C3b complex can activate the complement activation through the 
alternative pathway (Fig. 6 (c)). Preadsorbed albumin was also shown to be a substrate 
for covalent binding of C3b [42]. Adsorption of C3 induces conformational changes that 
transform C3 into a C3b-like molecule that is able to participate in the functioning of 
the alternative convertase [41] (Fig. 6 (b)). 
These results suggest that adsorbed serum proteins have the potential ability to trigger 
both the classical and the alternative pathways depending on the type of the adsorbed 
protein. 
 
4.2.2. Complement activation by SAMs with various functional groups 
The effect of surface functional groups on complement activation has been studied by 
taking advantage of SAMs composed of alkanethiols. Figure 7 compares the amounts of 
protein adsorbed on SAMs carrying hydroxyl (OH), amino (NH2), methyl (CH3) and 
carboxyl (COOH) terminal groups from human serum [68,70]. SAMs modified with 
hydroxyl groups (OH-SAM) showed the highest amount of adsorbed serum proteins 
(Fig. 7). Four solutions of different antibodies were applied to the adsorbed protein 
layers to analyze the activation pathway. A large amount of anti-C3b antibody was 
bound to the adsorbed protein layer, formed on OH-SAM, indicating that strong 
complement activation occurs on OH-SAM through the alternative pathway. This result 
is consistent with earlier studies that demonstrated that hemodialysis membranes made 
of cellulose or its derivatives activated the complement system [3,4]. Notably, anti-C1q, 
anti-albumin or anti-IgG were hardly detected in the protein layer formed on OH-SAM. 
Most of the adsorbed protein in the layer is composed of C3b and C3bBb. In contrast, 
SAMs carrying methyl (CH3), amine (NH2), and carboxylic acid (COOH) terminal 
groups exhibited less binding of anti-C3b antibody, indicating that those functional 
groups are poor complement activators through either the classical or the alternative 
pathways. These results clearly demonstrate that surface functional groups greatly affect 
the complement activation behavior. 
The amino group, which is similar to the hydroxyl group in that both are nucleophiles, 
seems to be a potential activator for the complement system. Indeed, low molecular 
weight amines in blood react with the thioester group of C3 [76-78] and C3b [78]. 
However, SAMs carrying terminal amino group (NH2-SAM) did not exhibit high levels 
of C3b deposition [68] (Fig. 7). ELISA study also showed that the amount of C3a 
released into serum after exposure to NH2-SAM was much less than with OH-SAM. 
About 750 µg/cm2 of protein, mainly albumin, was adsorbed onto the NH2-SAM. NH2-
SAM was a much weaker activator due to coverage of nucleophilic amino groups with 
serum proteins.    
To examine the effect of hydroxyl density on complement activation, mixed SAMs with 
different ratios of hydroxyl and methyl groups were prepared using 11-mercapto-1-
undecanethiol and methyl-terminated alkanethiol with different alkyl chain length (1-
nonanethiol, 1-dodecanethiol, or 1-hexadecanethiol). Figure 8 shows deposition of 
protein from human serum on the mixed SAMs [54]. The amounts of adsorbed serum 
proteins increased with increasing surface fraction of hydroxyl groups C11-OH (Fig. 8). 
We also examined adsorption of human serum albumin (HSA) to mixed SAMs. HSA 
did not adsorb to SAMs with high hydroxyl fraction. The amount of bound anti-C3b 
antibody also increased with increasing surface fraction of hydroxyl group [54]. A small 
amount of C3b is naturally produced in the liquid phase, serum, by hydrolysis. It is 
covalently immobilized on the surface through the ester exchange reaction between the 
thioester of C3b and surface hydroxyl groups. The C3b is stabilized on the surface and 
then becomes the C3 convertase, C3bBb. It accelerates activation of the complement 
system. The surface with higher density of hydroxyl groups becomes a potent activator 
of the complement through the alternative pathway.  
Although OH-SAM exhibited low adsorption of albumin, the surface did not fully 
inhibit nonspecific protein adsorption even in the presence of EDTA [67]. Tengvall et al. 
reported complement activation on a surface modified with 3-mercapto-1,2-propanediol 
using ellipsometry [33]. They showed that IgG and C1q was transiently detected on the 
surface exposed to human serum by their specific antibodies. They speculated that IgG 
adsorbed on the surfaces initially activates the complement through the classical 
pathway and then deposited C3b accelerated its activation through the alternative 
pathway. Further studies including composition of initially adsorbed proteins and their 
conformation on the surface are required to discuss the detailed mechanism of the 
complement activation by surfaces carrying hydroxyl groups. 
 
4.2.3. Complement activation by polymer-coated surfaces 
Coating of biomaterials and biosensors with water soluble polymers including 
poly(ethylene glycol) (PEG), dextran, and poly(vinyl alcohol) (PVA) has been shown to 
effectively prevent nonspecific adsorption of proteins. PEG has been frequently used to 
shield the antigenicity of proteinaceous drugs from the host immune system, and to 
prolong the circulating half-life of drug-loaded nanoparticles [79-81]. However, 
unanticipated body reactions such as hypersensitivity reactions caused by PEG-
modified liposomes [82-85] and rapid clearance of PEG-modified liposomes from blood 
have been reported [86]. The complement system is suggested to be associated with 
these body reactions [87-89], but the detailed mechanism remains unclear. To aid the 
development of PEG-modified materials for biomedical and pharmaceutical use, the 
interactions of complement proteins with PEG-modified surfaces have been studied in 
some detail.  
Two surfaces modified with tri(ethylene glycol)-terminated alkanethiol (HS-TEGOH) 
and methoxy-terminated PEG-thiol (HS-mPEG) were employed as model surfaces in 
our studies [90]. While these surfaces demonstrated nonspecific protein adsorption from 
solutions of a single protein such as albumin, IgG, and fibrinogen [58,91,92], large 
amounts of serum proteins were deposited on the HS-TEGOH surface when the surface 
was exposed to human serum (Fig. 9 (a)).  A large amount of anti-C3b antiserum also 
bound to the protein layer formed on the HS-TEGOH surface (Fig. 9 (b)), indicating 
that the complement system is strongly activated by the HS-TEGOH surface. In 
addition, when human serum was supplemented with EDTA, which can inhibit the 
complement activation, deposition of serum proteins was greatly reduced. HS-TEGOH 
affords a non-fouling surface in the presence of EDTA as observed in single protein 
solutions. In addition, when human serum was supplemented with EGTA and Mg2+, a 
large amount of anti-C3b antibody was immobilized on the protein layer formed on the 
HS-TEGOH surface. Those results indicate that C3b covalently binds to the terminal 
hydroxyl group of HS-TEGOH (Fig. 6 (d)) and the HS-TEGOH surface activates the 
complement system through the alternative pathway. In contrast, small amounts of 
serum proteins were deposited on the HS-mPEG surface which carries a methoxy 
terminal group, and no anti-C3b antibody was immobilized on the surface previously 
exposed to human serum. These results suggest that soluble PEG chains can inhibit non-
specific protein adsorption and the terminal group of PEG can determine the 
complement activation behavior. These results are consistent with previous studies in 
which nanoparticles modified with methoxy-terminated PEG reduce complement 
activation, cellular uptake and prolong circulation lifetime in blood, while the stealth 
properties of PEG-modified nanoparticles depend on their size, and surface density of 
PEG [87,89,93]. 
Although the HS-mPEG surface just after preparation did not induce complement 
activation, it became a stronger activator upon storage under room light at room 
temperature [69,90]. Conversion of the HS-mPEG surface into a complement-activating 
surface highly depended on the storage conditions (temperature, light). Complement 
activation on the HS-mPEG surface was further accelerated by UV irradiation. Surface 
analyses using FTIR-RAS and XPS confirmed that the HS-mPEG surface was degraded 
during storage or UV irradiation [69]. Sufficient PEG chains remained to prevent 
protein adsorption on the HS-mPEG surface, if the complement activation was inhibited 
by EDTA.  
The PEG chains appear to be degraded by the following mechanism [94]: 
 
The resulting fragments of PEG chains carry hydroxyl groups at the terminal and thus 
have the ability to activate the complement activation as observed with the HS-TEGOH 
surface. Oxidation should be suppressed for future development of PEG-coated 
materials for use in biomedical applications. 
PVA and dextran are also useful to prevent nonspecific protein adsorption as observed 
with PEG. However, these polymers are expected to have the potential ability to activate 
the complement system due to the presence of many hydroxyl groups on the molecule 
as cellulose. Indeed, surfaces modified with PVA and dextran strongly activated the 
complement system [60]. These surfaces effectively prevented nonspecific adsorption of 
serum proteins. Deposition of C3b was not reduced even in the presence of EGTA-Mg2+, 
suggesting that the complement activation is mainly initiated through the alternative 
pathway. Interestingly, these polymers added to serum did not activate the complement 
system even when the amounts of the soluble polymers added to serum were 4 – 2000 
times higher than those on the polymer-immobilized surfaces. Videm et al. also reported 
that solutions of dextran, which have medicinal application as a blood substitute and a 
plasma expander, did not strongly activate the complement system at the dextran 
concentrations used in clinical settings [95]. These results suggest that conformation of 
polymer in solution and immobilized on solid surface determine the complement 
activation behavior.  
The potential of PVA immobilized surfaces as an activator of the complement system 
was examined in some detail [61]. PVA was immobilized on SAM of alkanethiol 
carrying a terminal aldehyde group by spin-coating PVA in the presence of HCl. The 
thickness of the PVA layers was controlled by the concentrations of PVA used for spin-
coating (Table 2). Complement activation by PVA surfaces highly depends on its 
thickness and annealing temperature [60] (Fig. 10). The complement system was 
strongly activated by a PVA immobilized surface with a dry thickness of 2.9 nm as 
indicated by large amounts of adsorbed serum proteins and subsequently bound anti-
C3b antibody, while it was poorly activated by a PVA surface with a dry thickness of 7.4 
nm. In addition, annealing of the latter for 2 h at 150 ºC converted the surface into a 
complement activating surface. Non-specific protein adsorption was prevented on all 
surfaces when serum supplemented with EDTA was used. On the other hand, large 
amounts of adsorbed proteins and bound anti-C3b antibodies were observed on PVA 
surfaces in serum supplemented with EGTA and Mg2+. These results suggest that the 
PVA surfaces activate the complement system through the alternative pathway. The 
difference in the complement activation ability of PVA layers was intimately related 
with the water content of the PVA layers (Table 2). A surface with a thick PVA layer, 
which poorly activates the complement system, showed high water content (86%), 
while surfaces with thin PVA layer and annealed thick PVA layer, which are strong 
complement activators, exhibited low water content (37 – 75%). We speculate that the 
difference between these PVA layers can be explained by accessibility of complement 
regulatory factors H and I to their respective binding sites between polymers and C3b. 
For the case of surfaces with poorly hydrated PVA layers, activator (factor B) is 
expected to interact with specific binding sites of C3b on poorly hydrated PVA layers, 
while factors H (155 kDa) and I (88 kDa) hardly have access to their binding sites on 
C3b since the binding sites are hindered by PVA chains and a planar substrate. On the 
other hand, for the case of surfaces with highly hydrated PVA layers, the regulators 
(factors H and I) accesses to their binding sites of C3b bound to highly hydrated PVA.  
These speculations can be also applicable to poor activation ability of polymers with 
hydroxyl groups (PVA and dextran) dissolved in serum. 
Effect of polymer conformations on complement activation was also reported [87,89,96-
99]. Hamad et al used polystyrene nanoparticles coated by poloxamine 908, a 
tetrafunctional polyethylene oxide – polypropylene oxide ethylenediamine block 
copolymer carrying terminal hydroxyl group [99]. They showed that polymer 
architecture from mushroom to brush configuration not only reduces the level of the 
complement activation but also switches complement activation pathway. These reports 
suggest that conformation of polymer should be controlled to design biomaterials 
including blood vessel prostheses, drug-loaded nanoparticles, and polymer-modified 
drug. Molecular basis of complement activation on polymer surfaces with different 
conformations is needed to be studied on the base of three dimensional molecular 
structures of complement proteins.  
 
5. Conclusions and perspectives 
Synthetic materials have been widely used for biomedical and pharmaceutical 
applications, such as blood vessel prostheses, hemodialysis membranes, and drug 
eluting systems and liposomes. For the successful development of biomaterials that will 
come in contact with blood, understanding and control of complement activation on 
biomaterials are essentially important. SPR is one of the analytical techniques that 
allows for in situ monitoring of complement activation on the surfaces of materials.  
Studies on complement activation on various material surfaces have revealed that: 
1. Protein adsorption behavior from human serum differs from that in a single 
protein solution. 
2. Surfaces carrying hydroxyl groups strongly activate the complement system 
through the alternative pathway. 
3. Surfaces carrying amino groups are poor activators of the complement system. 
4. Polymer layers presenting hydroxyl groups strongly activate the complement 
system through the alternative pathway. However, this behavior highly depends 
on the water content of the polymer layer. 
Although studies cited in this review and others made clear the mechanisms of the 
complement activation by the artificial materials, several points still remain to be 
clarified.  
1. What is the critical step for complement activation on a nonspecifically 
adsorbed protein layer? 
2. How does the water content of the polymer layer modulate the complement 
activation behavior? 
3. Do lipid bilayers or polymer-modified lipid bilayers activate the complement 
system? 
Recently, three dimensional structures of complement-relating proteins and their 
complexes have been revealed by X-ray diffraction and electron microscopy [100-107]. 
The structural studies provided deep insights into complement activation/regulation on 
the molecular level. Although advances in molecular biology have also provided 
detailed and comprehensive information about networks of complement 
activation/regulation, a complete understanding of its network reactions has yet to be 
accomplished. Recently, developments in systems biology have aided our understanding 
of dynamic biological networks using a mathematical model [108]. We have attempted 
to apply the methodology of systems biology to extend our understanding of the 
complement activation cascade induced by biomaterials. The combination of these 
studies with analytical techniques will ultimately allow us to understand the 
mechanisms of complement activation on biomaterials’s surfaces. 
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Figure captions 
Figure 1. (a) Schematic illustration of the Kretschmann configuration for SPR. Surface 
plasmon is excited at metal/ambient interface when the evanescent component of wave 
vector of incoming light (kev) is equal to the wave vector of the propagating surface 
plasmon (ksp). (b) Reflectance as a function of incident angle before (black) and after 
(red) adsorption of substances. (c) Schematic representation of a SPR apparatus. 
 
Figure 2. Schematic illustration of an SPR profile during a protein adsorption 
experiment. (a) Sequential step in protein adsorption onto a material surface; surface 
exposed to buffer (I), upon exposure to protein solution (II), adsorbed with protein (III), 
and rinsed with buffer (IV). (b) Reflectance as a function of incident angle before 
(black) and after (red) adsorption of proteins. A shift in the SPR angle (∆θSPR) occurs in 
a manner dependent on the amount of adsorbed proteins. (c) In real-time monitoring, 
reflectance at a specific incident angle (dashed line in (b)) is plotted as a function of 
time. Points I to IV correspond to steps in (a). Change in reflectance after protein 
adsorption (∆R) is finally converted to ∆θSPR to calculate the amount of adsorbed 
proteins. 
 
Figure 3. Model surfaces used for complement monitoring by SPR. 
 
Figure 4. Composition (a) and water contact angles (b) of SAMs formed from various 
reaction mixtures of 11-mercapto-1-undecanol and several methyl-terminated 
alkanethiols with different alkyl chain length. The composition of SAMs was 
determined by FTIR-RAS spectra. Modified from Ref. [54]. 
 
Figure 5. Time curve of normal human serum proteins adsorption on OH-SAM and 
subsequent binding of anti-C3b antiserum. Modified from Ref. [67]. 
 
Figure 6. Model of complement activation on a biomaterial surface. Nonspecifically 
adsorbed immunoglobulins (a) initiate the classical pathway while conformationally 
changed C3 upon nonspecific adsorption (b), C3b covalently bound to nonspecifically 
adsorbed serum proteins (c), and C3b covalently bound to hydroxyl or amino groups of 
biomaterial (d) initiate the alternative pathway. 
 
Figure 7. The amounts of adsorbed serum proteins from 10% human serum and the 
subsequent binding of antibodies to SAMs carrying different terminal groups. Asterisks 
indicate that adsorption of serum proteins or binding of anti-C3b antibody was not 
detected by SPR. Summarized from Ref. [68,70]. 
 
Figure 8. The amounts of adsorbed serum proteins from 10% human serum (open 
symbols) and adsorbed human serum albumin (HSA) (closed symbols) from a single 
HSA solution as a function of hydroxyl density of mixed SAMs carrying hydroxyl and 
methyl groups. Mixed SAMs were formed from various reaction mixtures of 11-
mercapto-1-undecanol and several methyl-terminated alkanethiols with different alkyl 
chain length (see Fig. 4). Modified from Ref. [54]. 
 
Figure 9. SPR sensorgrams during exposure of HS-TEGOH and HS-mPEG surfaces to 
10% human serum (a) and anti-C3b antiserum (b). Figures also include SPR 
sensorgrams when HS-TEGOH surface was exposed to 10% human serum in the 
presence of 10 mM EDTA to block the complement activation [90].  
 
Figure 10. Amounts of serum proteins adsorbed on PVA surfaces and subsequent 
binding of anti-C3b antibodies to serum protein layers formed on those surfaces. Data 
shown are means ± SD (n = 3). PVA percent: PVA concentration for spin-coating. Types 
of serum samples: serum, human serum; serum + EDTA, human serum + 10 mM 
EDTA; serum + EGTA, human serum + 10 mM EGTA + 2.5 mM MgCl2. Asterisks 
indicate that adsorption of serum proteins or binding of anti-C3b antibody was not 
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Serum Serum + EDTA
1% (annealed at 150ºC)
* * * * *
PVA
Table 1. Methods used for complement research 
 
 
 Requirement of 
materials 
Information Monitoring Labeling Detectable complement 
proteins 
SPR Metal thin layer 
on glass (gold, 
silver) 
Thickness Real-time No Adsorbed protein 
(e.g., Immunoglobulins, 




Thickness Real-time No Adsorbed protein 
(e.g., Immunoglobulins, 
C1q, C4, C3b, C3c) 
QCM Quartz Mass, 
viscoelasticity 
Real-time No Adsorbed protein 
(e.g., Immunoglobulins, 
C1q, C4, C3b, C3c) 




(e.g., C3a, Bb, C5a, 
SC5b-9) 














0.1% 33.5 ± 2.4 2.9 ± 0.1 4.6 ± 1.5 37 
0.2% 29.9 ± 1.8 2.9 ± 0.2 13.0 ± 2.4 78 
0.4% 25.4 ± 0.8 4.8 ± 0.2 34.9 ± 3.1 86 
0.7% 23.7 ± 1.5 6.4 ± 0.2 45.5 ± 2.1 86 
1% 22.6 ± 1.3 7.4 ± 0.3 53.3 ± 1.0 86 
1% (annealed) 35.0 ± 5.5 6.4 ± 0.1 25.4 ± 2.0 75 
a
: determined from (1 – d0/d1) x 100 
 
